Machina Capital S.A.S. reduced its holding in IDEX Corporation by 47.2% during the third quarter, selling 6,176 shares and leaving a position of 6,895 shares as reported in its latest Form 13F filing with the SEC. The remaining stake was valued at approximately $1.122 million at the time of filing. This divestiture represents one of the largest single-fund reductions in IDEX stock over the period and follows a strategy of portfolio rebalancing that has seen Machina Capital reallocate capital toward emerging industrial names.

Other hedge funds were active in adjusting their IDEX positions. Empowered Funds LLC added 54 shares, increasing its stake by 3.4% to 1,646 shares. Mirae Asset Global Investments lifted its holding by 8.9% through the acquisition of 971 shares, bringing its total to 11,901 shares valued at around $2.089 million. QRG Capital Management and DAVENPORT & Co LLC also expanded their positions by 13.6% and 58.5%, respectively, while HB Wealth Management initiated a new position worth roughly $206,000. Collectively, institutional investors now control 97.96% of IDEX’s outstanding shares, underscoring strong confidence in the company’s long-term industrial growth profile.

In its fourth quarter report, IDEX posted earnings per share of $2.10, exceeding consensus estimates by $0.06, on revenues of $899.1 million, up 4.2% year-over-year. Gross margin expanded by 60 basis points to 43.1% thanks to productivity initiatives and favorable price/cost dynamics. The company generated operating cash flow of $209.5 million and free cash flow of $189.8 million, reflecting solid conversion. Management set Q1 2026 EPS guidance at $1.73 to $1.78 and full-year guidance at $8.15 to $8.35, reinforced by order growth in data-center power solutions and strength in its Health & Science Technologies segment. The board also declared a quarterly dividend of $0.71 per share, equivalent to a $2.84 annualized payout and representing a 44.9% payout ratio.